Healthcare Global Enterprises Limited

rs,

Mumbai - 400051, Maharashtra, India BSE Limited, Compliance Department, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400001, Maharashtra, India Dear Sir/Madam, Subject : Stock Code : BSE –

rs1

Largest Pan-India Oncology Hospital Chain 2 22 4* 6 Center of Excellence (CoE) Cancer Care Centers1 Multi-specialty hospitals Day care centers Jaipur Ahmedabad Indore Ranchi Rajkot Bhavnagar B

55%

ngole Suchirayu Hubli Shimoga Vijaywada Kenya Bangalore LARGEST GEOGRAPHICAL REACH… 10 19 ~55% Number of states covered5 Number of cities covered5 Addressable market3 (population) 25 16/1

14%

G ONCOLOGY MARKET IN INDIA INDIA IS A SIGNIFICANTLY UNDER-COVERED CANCER INDUSTRY INRbn CAGR 13-14% Population coverage by cancer registries1 CAGR 12% 3% 263 3% 1% 151 1% 3% 97% 89% 2019

12%

NDER-COVERED CANCER INDUSTRY INRbn CAGR 13-14% Population coverage by cancer registries1 CAGR 12% 3% 263 3% 1% 151 1% 3% 97% 89% 2019 Population growth Cancer incidences Relapse driven

3%

COVERED CANCER INDUSTRY INRbn CAGR 13-14% Population coverage by cancer registries1 CAGR 12% 3% 263 3% 1% 151 1% 3% 97% 89% 2019 Population growth Cancer incidences Relapse driven Af

1%

R INDUSTRY INRbn CAGR 13-14% Population coverage by cancer registries1 CAGR 12% 3% 263 3% 1% 151 1% 3% 97% 89% 2019 Population growth Cancer incidences Relapse driven Affordability R

97%

CAGR 13-14% Population coverage by cancer registries1 CAGR 12% 3% 263 3% 1% 151 1% 3% 97% 89% 2019 Population growth Cancer incidences Relapse driven Affordability Realization 2024

89%

R 13-14% Population coverage by cancer registries1 CAGR 12% 3% 263 3% 1% 151 1% 3% 97% 89% 2019 Population growth Cancer incidences Relapse driven Affordability Realization 2024 2030E

41%

2019 Population growth Cancer incidences Relapse driven Affordability Realization 2024 2030E 41% 10% 1 in every 9 people in India to potentially suffer from cancer by 2025 Sources: Globacan 201

10%

Population growth Cancer incidences Relapse driven Affordability Realization 2024 2030E 41% 10% 1 in every 9 people in India to potentially suffer from cancer by 2025 Sources: Globacan 2018, IC

81%

key problems LOW EARLY-STAGE DIAGNOSIS IN INDIA… … LEADING TO HIGH MORTALITY TO INCIDENCE RATIO 81% 71% 73% 29% 31% 30% 19% 8% 31% 26% 25% 15% 51% 52% 56% 17% 22% 28% 33% 23% 88%

“Although the Company believes that such forward ‐ looking statements are based on reasonable assumptions, it can give no assurance that such expectations will be met.”

“c o m 44 Industry Opportunity LARGE AND GROWING ONCOLOGY MARKET IN INDIA INDIA IS A SIGNIFICANTLY UNDER-COVERED CANCER INDUSTRY INRbn CAGR 13-14% Population coverage by cancer registries1 CAGR 12% 3% 263 3% 1% 151 1% 3% 97% 89% 2019 Population growth Cancer incidences Relapse driven Affordability Realization 2024 2030E 41% 10% 1 in every 9 people in India to potentially suffer from cancer by 2025 Sources: Globacan 2018, ICMR; NCRP Annual Report 2020, Industry Reports Note: 1 As of 2020 w w w .”

“c o m 19 Q1 FY26 FINANCIAL & OPERATIONAL HIGHLIGHTS SUBASENI LENKA, CANCER WINNER I am eternally thankful to Dr.”

“No 1 2 Particulars Capex incurred till 30 th June 2025 Total Planned Capex Expected Operational period North Bangalore Whitefield (Extension of Bangalore - COE) 288 137 900 290 H2 FY26 H2 FY26 1.”

“c o m Q1 FY26 Consolidated Profit & Loss Account Profit and Loss (in Rs.”

Subject

1

Subject

Stock Code : BSE – 539787, NSE – HCG Investor Presentation We wish to inform you that the Board of Directors of the Company, at their meeting held on August 01, 2025, inter alia, has considered and approved the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2025 (“Financial Results”). We enclose herewith the Presentation on the Financial Results of the Company for the quarter ended June 30, 2025. Request you to take this on record. Thanking you, For HealthCare Global Enterprises Limited Sunu Manuel Company Secretary & Compliance Officer Encl: a/a. HealthCare Global Enterprises Limited HCG Tower, # 8, P Kalinga Rao Road, Sampangi Rama Nagar, Bangalore - 560027. 080 33669999 | info@hcgoncology.com | www.hcgoncology.com | CIN : L15200KA1998PLC023489 HEALTHCARE GLOBAL ENTERPRISES LIMITED I NV ESTOR P R ESENTATI ON August 2025 SAFE HARBOR This presentation and its contents are confidential and are not for release, publication or distr